Your browser doesn't support javascript.
loading
Robustness and reproducibility for AI learning in biomedical sciences: RENOIR.
Barberis, Alessandro; Aerts, Hugo J W L; Buffa, Francesca M.
Afiliación
  • Barberis A; Nuffield Department of Surgical Sciences, Medical Sciences Division, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford, OX3 7DQ, UK. dr.alessandro.barberis@gmail.com.
  • Aerts HJWL; Computational Biology and Integrative Genomics Lab, Department of Oncology, Medical Sciences Division, University of Oxford, Oxford, OX3 7DQ, UK. dr.alessandro.barberis@gmail.com.
  • Buffa FM; Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, MA, USA.
Sci Rep ; 14(1): 1933, 2024 01 22.
Article en En | MEDLINE | ID: mdl-38253545
ABSTRACT
Artificial intelligence (AI) techniques are increasingly applied across various domains, favoured by the growing acquisition and public availability of large, complex datasets. Despite this trend, AI publications often suffer from lack of reproducibility and poor generalisation of findings, undermining scientific value and contributing to global research waste. To address these issues and focusing on the learning aspect of the AI field, we present RENOIR (REpeated random sampliNg fOr machIne leaRning), a modular open-source platform for robust and reproducible machine learning (ML) analysis. RENOIR adopts standardised pipelines for model training and testing, introducing elements of novelty, such as the dependence of the performance of the algorithm on the sample size. Additionally, RENOIR offers automated generation of transparent and usable reports, aiming to enhance the quality and reproducibility of AI studies. To demonstrate the versatility of our tool, we applied it to benchmark datasets from health, computer science, and STEM (Science, Technology, Engineering, and Mathematics) domains. Furthermore, we showcase RENOIR's successful application in recently published studies, where it identified classifiers for SET2D and TP53 mutation status in cancer. Finally, we present a use case where RENOIR was employed to address a significant pharmacological challenge-predicting drug efficacy. RENOIR is freely available at https//github.com/alebarberis/renoir .
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Inteligencia Artificial Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Algoritmos / Inteligencia Artificial Tipo de estudio: Prognostic_studies Idioma: En Revista: Sci Rep Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido